Corrigendum to “Activation of Melanocortin Receptors MC1 and MC5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy”
In the article titled “Activation of Melanocortin Receptors MC1 and MC5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy” [1], an error was identified in Figure 3 as raised on PubPeer [2]. Figure 3, BMS-470539 8 weeks, is the same as Figure 3, BMS-470539 16 weeks. The authors explained that this was due to a mistake during manuscript preparation and the corrected figure, as approved by the editorial board, is shown below.
Figure 3
Representative pictures of FAG showed a regular course and caliber of retinal vessels without microvascular changes or vessel leakage at every time point following intravitreal injection of the MC1 melanocortin receptor agonist BMS-470539 and of the MC5 agonist PG-901. The number of mice for each group was n = 10 nondiabetic mice (baseline) and 8 diabetic mice with retinopathy.
